Epigenetic Drug Response Modeling for Personalized Cancer Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer diagnosis and treatment methods lack a sustainable, efficient, and personalized approach, failing to leverage the complex interplay between epigenetic modifications and molecular biology for optimized drug selection and treatment.
Innovation Solution
A dynamic anti-cancer drug response predictive method integrating multiple epigenetic factors with molecular biology, utilizing machine learning algorithms to construct a predictive model that includes causal and correlation relationships between DNA, RNA, and Protein layers, and employs supervised and unsupervised learning algorithms for data processing and model building.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If current cancer diagnosis and treatment methods are used, then treatment can be provided, but the approach lacks sustainability, efficiency, and personalization
Solution Approach 1:
The patent implements a dynamic predictive model that continuously updates cancer prognosis and drug response predictions by integrating new epigenetic data, molecular biology data, and treatment responses. The model adapts to individual patient characteristics and evolves with each treatment cycle, enabling personalized treatment adjustments that improve both efficiency and effectiveness.
Solution Approach 2:
The system changes parameters by incorporating multiple epigenetic factors (DNA methylation, histone modification, chromatin structure) alongside traditional molecular biology parameters. This multi-parameter integration allows the model to capture complex cancer mechanisms and predict treatment responses more accurately, enhancing both personalization and efficiency.
2Measurement precision
If multiple epigenetic factors are integrated with molecular biology, then predictive accuracy improves, but system complexity increases
Solution Approach 1:
The patent segments the complex system into distinct functional modules: epigenetic data processing module, molecular biology data processing module, machine learning prediction module, and treatment optimization module. Each module handles specific data types and processing tasks independently, then integrates results through standardized interfaces, reducing overall system complexity while maintaining high predictive accuracy.
Solution Approach 2:
The machine learning predictive model serves as an intermediary that bridges epigenetic factors and molecular biology data. It processes and integrates these complex data types through learned representations, transforming them into actionable treatment predictions. This intermediary layer simplifies the relationship between multiple data sources and the final output, making the system more manageable.
3Adaptability or versatility
If a comprehensive predictive model integrating multiple data types is built, then treatment personalization improves, but data processing complexity increases
Solution Approach 1:
The system performs preliminary data processing actions by pre-processing epigenetic data and molecular biology data separately before integration. Quality control, normalization, and feature engineering are performed in advance on each data type, reducing the complexity of subsequent integration steps. This preliminary action enables the comprehensive model to handle diverse data types systematically.
Solution Approach 2:
The patent adds a temporal dimension to data processing by incorporating time-series data from multiple treatment cycles. It also introduces a hierarchical dimension by organizing data at multiple levels (epigenetic level, genomic level, proteomic level). This dimensional expansion allows the system to process comprehensive data systematically, with each dimension handled by specialized processing routines that reduce overall complexity.
Data Source
AI summary
The present invention discloses a dynamic anti-cancer drug response predictive method and machine learning system with molecular biology as the core and integrated multiple epigenetic factors. More specifically, the present invention integrates multiple epigenetic data, predicts based on the central dogma, and builds a dynamic model. The system directly inputs the data from the cloud, accurately locates, and automatically pre-processes the data in the algorithm-required form. The disclosed method and machine learning system are always open and continuously integrate the latest scientific progress to achieve dynamic implementation. Combined with the targeted needs of cancer prediction, relevant algorithms that can highlight the characteristics of the data set are selected to allow the biological model to play the greatest leading role. Unsupervised and supervised algorithms are selected to be jointly constructed, and users can combine the conclusions of the two to draw answers jointly.